This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
| Device | P040029S010 |
| Classification Name | None |
| Applicant | |
| PMA | P040029 |
| Supplement | S010 |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P040029 | Original Filing | |
| S020 | 2021-06-29 | 30-day Notice |
| S019 | 2021-01-14 | 30-day Notice |
| S018 | ||
| S017 | ||
| S016 | 2020-08-12 | Normal 180 Day Track No User Fee |
| S015 | 2020-05-29 | Normal 180 Day Track |
| S014 | 2020-02-26 | Normal 180 Day Track No User Fee |
| S013 | ||
| S012 | 2020-01-31 | 30-day Notice |
| S011 | ||
| S010 | ||
| S009 | 2019-06-26 | Normal 180 Day Track |
| S008 | 2019-05-08 | Real-time Process |
| S007 | 2019-03-15 | 30-day Notice |
| S006 | ||
| S005 | 2017-08-09 | 30-day Notice |
| S004 | 2016-12-27 | Normal 180 Day Track |
| S003 | 2016-01-29 | Normal 180 Day Track No User Fee |
| S002 | 2015-08-03 | Normal 180 Day Track No User Fee |
| S001 | 2005-08-29 | Normal 180 Day Track No User Fee |
| Device ID | PMA | Supp |
|---|---|---|
| 85000713500232 | P040029 | 000 |
| 85000713599960 | P040029 | 000 |
| 85000713599991 | P040029 | 000 |
| 85000713599984 | P040029 | 000 |
| 85000713500102 | P040029 | 000 |
| 85000713500119 | P040029 | 000 |
| 85000713500126 | P040029 | 000 |
| 85000713500133 | P040029 | 000 |
| 85000713500140 | P040029 | 000 |
| 85000713500157 | P040029 | 000 |
| 85000713500164 | P040029 | 000 |
| 85000713500171 | P040029 | 000 |
| 85000713500188 | P040029 | 000 |
| 85000713500195 | P040029 | 000 |
| 85000713500218 | P040029 | 000 |
| 85000713500225 | P040029 | 000 |
| 85000713599977 | P040029 | 000 |